ORIGINAL RESEARCH article
Front. Oncol.
Sec. Gastrointestinal Cancers: Gastric and Esophageal Cancers
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1619106
This article is part of the Research TopicReal-World Clinical and Translational Research in Gastrointestinal CancersView all 12 articles
Prognostic Value of the Log Odds of Negative Lymph Nodes/T stage ratio (LONT) in Postoperative Esophageal Cancer: A SEER-Based Study
Provisionally accepted- Fujian Medical University Union Hospital, Fuzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Surgery remains the primary treatment for patients with esophageal cancer (EC), but postoperative prognosis is often unsatisfactory. We developed an interactive web-based tool to estimate cancer-specific survival (CSS) in patients with T1~3N0~2M0 EC after surgery, based on the log odds of negative lymph nodes/T stage ratio (LONT). A total of 2,221 patients were selected from the Surveillance, Epidemiology, and End Results (SEER) database and randomly divided into training and testing sets. Univariate Cox regression analysis revealed that age, sex, T stage, N stage, chemotherapy, and LONT were significantly associated with CSS. ROC curve comparisons using Cox regression and random survival forest (RSF) models showed that LONT outperformed N stage in predictive accuracy, particularly for 1-year CSS. Decision curve analysis (DCA) and calibration curves indicated that the model had high predictive accuracy. Finally, we developed an interactive web-based tool of effectively estimating 1-, 3-, and 5-years CSS and survival trends in postoperative patients with T1~3N0~2M0 EC.
Keywords: esophageal cancer, LONT, RSF, postoperative, SEER
Received: 27 Apr 2025; Accepted: 31 Jul 2025.
Copyright: © 2025 Lin, Chen, Lu, Huang, Han and Kang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Ziyang Han, Fujian Medical University Union Hospital, Fuzhou, China
Mingqiang Kang, Fujian Medical University Union Hospital, Fuzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.